1
Return

Prognostic potential of circulatory miR-19a-3p, miR-19b-3p, and miR-329-3p for future hypertension diagnosis

delete2026-05-01
delete0
PRE
AI
D
Daria Kostiniuk *
A
Antti Blankenstein
S
Sonja Rajić
J
Joanna Ciantar
N
Nina Mononen
L
Leo-Pekka Lyytikäinen
I
Ilkka Seppälä
P
Pashupati P. Mishra
M
Markus Juonala
M
Mélanie Waldenberger
M
Marko Elovainio
N
Niku Oksala
M
Mika Kähönen
N
Nina Hutri
O
Olli Raitakari
M
M Kleber
W
W März
T
T Lehtimäki
S
Saara Marttila
E
Emma Raitoharju
DOI:10.1097/HJH.0000000000004272delete
deleteOriginal
deleteOriginal request for help
deleteShare
deleteSave
Abstract

Abstract

En 中文
MicroRNAs have been suggested as essential hypertension biomarkers, but evidence remains inconclusive due to limited high-throughput studies in population cohorts. We analyzed data from the Young Finns Study (YFS) from 2011 and 2018-2020 to assess cross-sectional and prospective associations between circulatory microRNAs, blood pressure (BP), and hypertension. Hypertension risk prediction potential was assessed using nested logistic and Weibull survival models; model performance was evaluated with likelihood ratio (LR) test and c-statistic. All models were adjusted with relevant risk factors. In 2011, whole blood microRNAs were profiled for 871 individuals (83 with hypertension); in 2018-2020, 760 were re-examined, with 67 newly diagnosed. Cross-sectionally, 16 miRNAs correlated with BP (Spearman, P-FDR < 0.05); miR-122-5p (fold change = 1.33) and miR-144-5p (fold change = -1.10) differentiated hypertensive individuals (U test, P-FDR < 0.05). Associations persisted in adjusted regression models and some replicated in LURIC (n = 999) and YFS serum data (n = 126). Prospectively, miR-19a-3p [odds ratio (OR) = 1.51, 95% confidence interval (95% CI): 1.14-2.18], miR-19b-3p (OR = 1.50, 95% CI:1.11-2.04), and miR-329-3p (OR = 0.58, 95% CI: 0.39-0.74) levels prognosed hypertension incident. miR-329-3p improved model fit (LR test, P = 2.85 & times;10(-4)) and discrimination (c-statistic = 0.849, Delta = 0.026). miR-19b-3p predicted time to onset (hazard ratio = 2.13, 95% CI: 1.38-4.45), improving model fit (LR test, P = 0.0012) and time-dependent discrimination at 7 and 8-year horizons. Our findings highlight both novel and previously reported miRNAs associating with BP and hypertension and suggest that miR-329-3p, miR-19a-3p, and miR-19b-3p as promising candidates for further investigation in hypertension risk prediction.
Keywords:
blood pressure
essential hypertension
miRNA
prospective study

Journal

Journal of Hypertension cover
Journal of Hypertension
IF:
4.1
Papers:
2.4W
Citations:
1.7W

Organization

H
helmholtz association
Scholars:
5.6K
Papers: 2.1K
Citations: 6
T
Tampere University Hospital
Scholars:
142
Papers: 90
Citations: 4.8K
U
University of Helsinki
Scholars:
4.2K
Papers: 1.7K
Citations: 5.1W
H
helmholtz-zentrum fuer materialien und energie gmbh (hzb)
Scholars:
3.4K
Papers: 2.3K
Citations: 3
T
tampere university
Scholars:
1.8K
Papers: 817
Citations: 0
U
university of turku
Scholars:
2.0K
Papers: 893
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers